Vassiliki Douka

Splenic Marginal-zone Lymphoma: One or More Entities? A Histologic, Immunohistochemical, and Molecular Study of 42 Cases

Theodora Papadaki, Chrysoula Belessi, Evi Pouliou et al. · The American Journal of Surgical Pathology · 2007 · 52 citations

Medicine, Oncology, Pathology +17

Immunoglobulin Heavy- And Light-chain Repertoire in Splenic Marginal Zone Lymphoma

Chrysoula Belessi, Theodora Papadaki, Evangelia Kalagiakou et al. · Molecular Medicine · 2004 · 52 citations · Full text

Life Sciences, Immunology, Oncology +17

Long-term outcomes of total body irradiation plus cyclophosphamide versus busulfan plus cyclophosphamide as conditioning regimen for acute lymphoblastic leukemia: a comparative study

Ioanna Sakellari, Eleni Gavriilaki, Konstantinos Chatziioannou et al. · Annals of Hematology · 2018 · 36 citations

Medicine, Hematology, Oncology +17

Transferrin receptor-1 and 2 expression in chronic lymphocytic leukemia

Tatjana Smilevska, Chrysoula Belessi, Aliki Tsompanakou et al. · Leukemia Research · 2005 · 32 citations

Life Sciences, Immunology, Oncology +9

IgG-Switched CLL Has a Distinct Immunogenetic Signature from the Common MD Variant: Ontogenetic Implications

Anna Vardi, Andreas Agathangelidis, Lesley‐Ann Sutton et al. · Clinical Cancer Research · 2013 · 31 citations · Full text

Life Sciences, Bioinformatics, Immunology +17